Show simple item record

dc.contributor.authorBoyle, Geraldine*
dc.date.accessioned2014-12-19T09:57:40Z
dc.date.available2014-12-19T09:57:40Z
dc.date.issued2008
dc.identifier.citationBoyle, G. (2008) Controlling behaviour using neuroleptic drugs: the role of the Mental capacity act 2005 in protecting the liberty of people with dementia. Disability & Society, 23 (7), 759-771
dc.identifier.urihttp://hdl.handle.net/10454/6810
dc.description.abstractThe use of neuroleptic drugs to mediate the behaviour of people with dementia living in care homes can lead to them being deprived of their liberty. Whilst regulation has been successful in reducing neuroleptic prescribing in the USA, policy guidance has been unsuccessful in reducing the use of these drugs in the UK. Yet the Mental capacity act 2005 aimed to protect the liberty of people lacking capacity and provided safeguards to ensure that they are not inappropriately deprived of their liberty in institutions. This article highlights the potential for using this law to identify when neuroleptic prescribing in care homes would deprive people with dementia of their liberty and, in turn, to act as a check on prescribing levels. However, the extent to which the Act can promote and protect the right to liberty of people with dementia is constrained by a lack of access to social rights.
dc.relation.isreferencedbyPii 906327424: Doi 10.1080/09687590802469255
dc.subjectpeople with dementia
dc.subjectbehaviour
dc.subjectneuroleptic drugs
dc.subjectliberty
dc.subjectlegislation
dc.subjectnursing-home care
dc.subjectpsychological symptoms
dc.subjectolder-people
dc.subjectpsychotropic-drugs
dc.subjectimpact
dc.subjectfacilities
dc.subjectenvironments
dc.subjectregulations
dc.subjectprevalence
dc.subjectguidelines
dc.titleControlling behaviour using neuroleptic drugs: the role of the Mental capacity act 2005 in protecting the liberty of people with dementia
dc.typearticle


This item appears in the following Collection(s)

Show simple item record